 kistrin polypeptid platelet gpiib/iiia receptor antagonist enhanc sustain coronari arteri thrombolysi recombin tissue-typ plasminogen activ canin prepar background kistrin acid polypeptid venom malayan pit agkistrodon rhodostoma platelet gpiib/iiia receptor effect thrombolysi reocclus administr recombin tissue-typ plasminogen activ rt-pa canin model coronari arteri thrombosi method result coronari patenc hour ultrason flow probe coronari angiographi rt-pa bolu inject interv recan maximum bolus group dog control group intraven heparin bolu unit hour group heparin mg/kg kistrin inject infus period control group dog minut cyclic reflow reocclus kistrin dose mg/kg time minut reocclus mg/kg kistrin anim minut reocclus anim kistrin dose-rel prolong templat bleed time mg/kg kistrin bleed time minut infus minut infus minut minut end infus kistrin dose-rel inhibit platelet aggreg adp collagen mg/kg kistrin platelet aggreg infus end observ period patholog examin recan coronari arteri segment dog mg/kg patent arteri platelet intim surfac conclus kistrin rate extent thrombolysi dose rt-pa reocclus effect dose transient prolong bleed time inhibit platelet aggreg kistrin promis adjunct treatment thrombolyt agent patient acut myocardi infarct